ArticleJournal of cancer research and clinical oncology2012

Growth inhibitory effect of dihydroartemisinin on Bcr/Abl+ chronic myeloid leukemia K562 cells involve AKT, ERK and NF-κB modulation.

Jun Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.